This compound is primarily used in the synthesis of pharmaceutical intermediates, particularly in the development of active pharmaceutical ingredients (APIs) for therapeutic drugs. Its structure, featuring a trifluoromethylphenyl group and a tert-butoxycarbonyl (Boc) protected amine, makes it valuable in peptide synthesis and medicinal chemistry. It is often employed in the creation of compounds targeting specific biological pathways, such as enzyme inhibition or receptor modulation. Additionally, its chiral nature allows for the production of enantiomerically pure substances, which is critical in drug design to ensure efficacy and reduce side effects. The trifluoromethyl group enhances the metabolic stability and bioavailability of the resulting molecules, making it a key component in the development of drugs with improved pharmacokinetic properties.